Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial

Abstract The CLARITY trial (Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease) is a two-arm, multi-centre, randomised controlled trial being run in India and Australia that investigates the effectiveness of angiotensin receptor blockers in addition to standard c...

Description complète

Détails bibliographiques

Auteurs principaux:	J. M. McGree, C. Hockham, S. Kotwal, A. Wilcox, A. Bassi, C. Pollock, L. M. Burrell, T. Snelling, V. Jha, M. Jardine, M. Jones, for the CLARITY Trial Steering Committee
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2022-04-01
Collection:	Trials
Sujets:	Adaptive sample size Angiotensin receptor blockers Bayesian design Clinical trial Coronavirus Protocol
Accès en ligne:	https://doi.org/10.1186/s13063-022-06167-2
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!